Breast cancer during pregnancy of Luminal A type overexpressed CXCL13

Fumi Nozaki, Yoko Nakanishi, Tomoyuki Tanino, Tomohiro Ochi, Reika In, Yuka Kajiura, Kumiko Kida, Junko Takei, Atsushi Yoshida, Naoki Kanomata, Atsuko Kitano, Hideko Yamauchi, Shinobu Masuda

Research output: Contribution to journalArticlepeer-review

Abstract

Pregnancy-associated breast cancer has been increasing. In this study, we analyzed patients with breast cancer that occurred during pregnancy (PrBC) and compared their genetic profiles with those of patients with breast cancer that did not occur during pregnancy, within 1 year after childbirth nor during lactation (non-PrBC). We performed gene expression analyses of patients with PrBC and non-PrBC using microarrays and qRT-PCR. Microarray analysis showed that 355 genes were upregulated in the luminal-type PrBC group compared to those in the non-PrBC group. The C-X-C motif chemokine ligand 13 (CXCL13) gene was the most upregulated in the PrBC group compared to that in the non-PrBC group, especially in the luminal A-type (p = 0.016). This result was corroborated by the qRT-PCR analysis of microdissected cancer cells (p < 0.001). A negative correlation was observed between CXCL13 and estrogen receptor 1 (ESR1) mRNA expression levels in luminal A-type breast carcinoma (p < 0.001). Our results provide clues for a better understanding of breast cancer pathogenesis during pregnancy.

Original languageEnglish
Pages (from-to)592-603
Number of pages12
JournalPathology International
Volume74
Issue number10
DOIs
Publication statusPublished - Oct 2024

Keywords

  • breast cancer
  • breast cancer during pregnancy (PrBC)
  • CXCL13
  • pregnancy
  • pregnancy-associated breast cancer (PABC)

Fingerprint

Dive into the research topics of 'Breast cancer during pregnancy of Luminal A type overexpressed CXCL13'. Together they form a unique fingerprint.

Cite this